Cargando…
Nanoformulation of Paclitaxel: Exploring the Cyclodextrin / PLGA Nano Delivery Carrier to Slow Down Paclitaxel Release, Enhance Accumulation in Vivo
Background: Improving the aggregation and penetration in tumor sites increases the anti-tumor efficacy of nanomedicine. In the current study, we designed cyclodextrin modified PLGA nanoparticles loaded with paclitaxel to elevate the accumulation and prolong circulation of chemotherapy drugs in vivo....
Autores principales: | Ma, Peilin, Huang, JiaYing, Liu, Jinling, Zhu, Yi, Chen, Jiahong, Chen, Junming, Lei, Lunwen, Guan, Ziyun, Ban, Junfeng, Lu, Zhufen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088884/ https://www.ncbi.nlm.nih.gov/pubmed/37056390 http://dx.doi.org/10.7150/jca.82410 |
Ejemplares similares
-
Effect of a 2-HP-β-Cyclodextrin Formulation on the Biological Transport and Delivery of Chemotherapeutic PLGA Nanoparticles
por: Zheng, Kangyu, et al.
Publicado: (2021) -
Self-assembled nanoformulations of paclitaxel for enhanced cancer theranostics
por: Pei, Qing, et al.
Publicado: (2023) -
Construction of gastric cancer patient-derived organoids and their utilization in a comparative study of clinically used paclitaxel nanoformulations
por: Zou, Jiale, et al.
Publicado: (2022) -
Comparative colloidal stability, antitumor efficacy, and immunosuppressive effect of commercial paclitaxel nanoformulations
por: Ye, Jun, et al.
Publicado: (2021) -
Investigation of Effective Parameters on Size of Paclitaxel Loaded PLGA Nanoparticles
por: Madani, Fatemeh, et al.
Publicado: (2018)